These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30828619)

  • 1. Calcium electroporation for recurrent head and neck cancer: A clinical phase I study.
    Plaschke CC; Gehl J; Johannesen HH; Fischer BM; Kjaer A; Lomholt AF; Wessel I
    Laryngoscope Investig Otolaryngol; 2019 Feb; 4(1):49-56. PubMed ID: 30828619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroporation therapy for head and neck cancer including carotid artery involvement.
    Allegretti JP; Panje WR
    Laryngoscope; 2001 Jan; 111(1):52-6. PubMed ID: 11192900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.
    Drugs R D; 2004; 5(5):293-6. PubMed ID: 15357628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroporation therapy: a new approach for the treatment of head and neck cancer.
    Hofmann GA; Dev SB; Dimmer S; Nanda GS
    IEEE Trans Biomed Eng; 1999 Jun; 46(6):752-9. PubMed ID: 10356882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium electroporation in cutaneous metastases - A non-randomised phase II multicentre clinical trial.
    Vissing M; Pervan M; Pløen J; Schnefeldt M; Rafaelsen SR; Jensen LH; Rody A; Gehl J
    Eur J Surg Oncol; 2023 Sep; 49(9):106925. PubMed ID: 37268521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic calcium electroporation for colorectal cancer: a phase I study.
    Broholm M; Vogelsang R; Bulut M; Stigaard T; Falk H; Frandsen S; Pedersen DL; Perner T; Fiehn AK; Mølholm I; Bzorek M; Rosen AW; Andersen CSA; Pallisgaard N; Gögenur I; Gehl J
    Endosc Int Open; 2023 May; 11(5):E451-E459. PubMed ID: 37180313
    [No Abstract]   [Full Text] [Related]  

  • 7. The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
    Plaschke CC; Johannesen HH; Hansen RH; Hendel HW; Kiss K; Gehl J; Wessel I
    Head Neck; 2019 Feb; 41(2):329-339. PubMed ID: 30552847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative Treatment of Esophageal Cancer Using Calcium Electroporation.
    Egeland C; Baeksgaard L; Gehl J; Gögenur I; Achiam MP
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck.
    Bloom DC; Goldfarb PM
    Eur J Surg Oncol; 2005 Nov; 31(9):1029-35. PubMed ID: 16150565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation on quality of life and progression-free survival in patients with pancreatic cancer: IREC clinical study.
    Rudno-Rudzińska J; Kielan W; Guziński M; Kulbacka J
    Adv Clin Exp Med; 2021 Jul; 30(7):765-770. PubMed ID: 34313408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Review of Calcium Electroporation -A Novel Cancer Treatment Modality.
    Frandsen SK; Vissing M; Gehl J
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors.
    Duvillard C; Romanet P; Cosmidis A; Beaudouin N; Chauffert B
    Ann Otol Rhinol Laryngol; 2004 Mar; 113(3 Pt 1):229-33. PubMed ID: 15053208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy.
    Falk H; Matthiessen LW; Wooler G; Gehl J
    Acta Oncol; 2018 Mar; 57(3):311-319. PubMed ID: 28816072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology evaluation: tgDCC-E1A, targeted genetics/MD Anderson.
    Wagner JA
    Curr Opin Mol Ther; 1999 Apr; 1(2):266-70. PubMed ID: 11715950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
    Schöffski P; Catimel G; Planting AS; Droz JP; Verweij J; Schrijvers D; Gras L; Schrijvers A; Wanders J; Hanauske AR
    Ann Oncol; 1999 Jan; 10(1):119-22. PubMed ID: 10076732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers.
    Plaschke CC; Bertino G; McCaul JA; Grau JJ; de Bree R; Sersa G; Occhini A; Groselj A; Langdon C; Heuveling DA; Cemazar M; Strojan P; Leemans CR; Benazzo M; De Terlizzi F; Wessel I; Gehl J
    Eur J Cancer; 2017 Dec; 87():172-181. PubMed ID: 29156298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).
    Lamont JP; Nemunaitis J; Kuhn JA; Landers SA; McCarty TM
    Ann Surg Oncol; 2000 Sep; 7(8):588-92. PubMed ID: 11005557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and Malignant Cells Exhibit Differential Responses to Calcium Electroporation.
    Frandsen SK; Krüger MB; Mangalanathan UM; Tramm T; Mahmood F; Novak I; Gehl J
    Cancer Res; 2017 Aug; 77(16):4389-4401. PubMed ID: 28760856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    Soulières D; Faivre S; Mesía R; Remenár É; Li SH; Karpenko A; Dechaphunkul A; Ochsenreither S; Kiss LA; Lin JC; Nagarkar R; Tamás L; Kim SB; Erfán J; Alyasova A; Kasper S; Barone C; Turri S; Chakravartty A; Chol M; Aimone P; Hirawat S; Licitra L
    Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.